Skip to main content

Table 1 Demographic data of SLE patients (n = 27)

From: Hydroxychloroquine inhibits CD154 expression in CD4+ T lymphocytes of systemic lupus erythematosus through NFAT, but not STAT5, signaling

Clinical characteristic Demographic data
Age (years) 33.9 ± 13
Sex, female:male 26:1
Duration (years) 7.7 ± 7.2
SLEDAI score 11.8 ± 9.2
Major organ involvement
 Nephritis 48% (13/27)
 Cytopenia 22% (6/27)
 Central nervous system 22% (6/27)
Immunosuppressants
 Corticosteroid 100%
 Hydroxychloroquine 7%
 Azathioprine 33%
 Mycophenolate mofetil 40%
 Cyclophosphamide 11%
Immunological level
 dsDNA Ab 108.1 ± 148.7
 C3 74.4 ± 34.4
 C4 14.7 ± 10.6
 ACA-IgG 10.1 ± 13.1
 ESR 49.2 ± 51.5
  1. Data presented as mean ± standard deviation or percentage (number/total)
  2. SLE systemic lupus erythematosus, SLEDAI SLE Disease Activity Index, ESR erythrocyte sedimentation rate, dsDNA Ab anti-double-strand DNA antibody, ACA-IgG anti-cardiolipin IgG